Highmount Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$3.43M Buy
35,214
+950
+3% +$95.1K 0.88% 30
2015
Q1
$3.45M Sell
34,264
-105
-0.3% -$10.7K 0.84% 32
2014
Q4
$3.59M Buy
34,369
+111
+0.3% +$11.7K 0.88% 33
2014
Q3
$3.65M Sell
34,258
-30
-0.1% -$3.11K 0.91% 32
2014
Q2
$3.59M Sell
34,288
-913
-3% -$92.3K 0.86% 31
2014
Q1
$3.46M Sell
35,201
-476
-1% -$44.1K 0.8% 35
2013
Q4
$3.27M Buy
35,677
+1,880
+6% +$173K 0.75% 34
2013
Q3
$2.93M Buy
33,797
+389
+1% +$34.9K 0.72% 34
2013
Q2
$2.87M Buy
+33,408
New +$2.84M 0.75% 36

Other funds holding JNJ

Highmount Capital's JNJ Position: Q2 2015 in Review

Highmount Capital increased its Johnson & Johnson (JNJ) stake by 2.8% in Q2 2015, buying an estimated $95.1K and bringing the position to 35,214 shares worth $3.43M. The position accounts for 0.88% of the portfolio, ranked #30.

Highmount Capital first reported a position in JNJ in Q2 2013 and has held it in 9 quarters since. The position peaked at $3.65M in Q3 2014. 2,106 funds tracked by Wall St. Rank hold JNJ as of Q2 2015.

  • Highmount Capital held 35,214 shares of Johnson & Johnson worth $3.43M as of Q2 2015.
  • Highmount Capital bought 950 Johnson & Johnson shares in Q2 2015, an estimated $95.1K.
  • Johnson & Johnson made up 0.88% of Highmount Capital's portfolio in Q2 2015, its #30 holding.
  • Highmount Capital first reported a position in Johnson & Johnson in Q2 2013 and has held it in 9 quarters since.
  • Highmount Capital's Johnson & Johnson position peaked at $3.65M in Q3 2014.
  • 2,106 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2015.

Based on Highmount Capital's 13F filing for Q2 2015, filed 14 Aug 2015.